(Q44066679)

29 November 2017

title

Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes (English)

1 reference

29 November 2017

main subject

prostatic hypertrophy

1 reference

1 reference

1

Claus G Roehrborn

1 reference

29 November 2017

John D McConnell

2

1 reference

29 November 2017

Brian Saltzman

3

1 reference

29 November 2017

Donald Bergner

4

1 reference

29 November 2017

Todd Gray

5

1 reference

29 November 2017

Perinchery Narayan

6

1 reference

29 November 2017

Thomas J Cook

7

1 reference

29 November 2017

Amy O Johnson-Levonas

8

1 reference

29 November 2017

Wilson A Quezada

9

1 reference

29 November 2017

Joanne Waldstreicher

10

1 reference

29 November 2017

PLESS Study Group. Proscar Long-term Efficacy and Safety Study

11

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

42

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

1-6

1 reference

Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

Symptoms and signs of prostatism as risk factors for prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900210-5

7 January 2021

10.1016/S0302-2838(02)00210-5

Identifiers

DOI

1 reference

29 November 2017

1 reference